|4Mar 1, 6:43 PM ET

AYTU BIOSCIENCE, INC 4

4 · AYTU BIOSCIENCE, INC · Filed Mar 1, 2017

Insider Transaction Report

Form 4
Period: 2017-02-27
Disbrow Jarrett
Chief Business Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2017-02-27$0.75/sh+187,500$140,625601,004 total
  • Exercise/Conversion

    Warrant to Purchase Common Stock

    2017-02-2720,8340 total
    Exercise: $6.00From: 2016-05-06Exp: 2021-05-06Common Stock (20,834 underlying)
  • Exercise/Conversion

    Warrant to Purchase Common Stock

    2017-02-27166,6660 total
    Exercise: $1.86From: 2017-11-02Exp: 2021-11-02Common Stock (166,666 underlying)
Holdings
  • Employee Stock Option Grant

    Exercise: $3.23Exp: 2025-11-11Common Stock (50,000 underlying)
    50,000
  • Employee Stock Option Grant

    Exercise: $3.23Exp: 2026-07-07Common Stock (60,000 underlying)
    60,000
Footnotes (3)
  • [F1]Of these shares, 165,000 are restricted shares that vest on July 7, 2026, subject to earlier vesting in certain situations.
  • [F2]33.3% vest on November 11, 2016, 33.3% vest on November 11, 2017 and 33.3% vest on November 11, 2018, subject to the Grantee's continued service as an employee on such dates.
  • [F3]33.3% vests on the one year, two year and three year anniversary of the date of grant, subject to the Grantee's continued service as an employee on such dates.

Documents

1 file
  • 4
    doc4_4571.xmlPrimary

    PRIMARY DOCUMENT